Updated Jul. 2, 2012 at 7:49 a.m.

Premium Lock Trial results accelerate potential blockbuster GSK respiratory drug

Published: 2012-07-02 07:39:00
Updated: 2012-07-02 07:49:30

Print this blog post
GSK GSK

Glaxo and partner Theravance began a collaboration a decade ago to develop respiratory drugs to help succeed Advair, Glaxo's aging best-seller....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll